This resolution expresses House support for designating June 1-7, 2026, as "Hidradenitis Suppurativa Awareness Week" to raise public understanding of a chronic inflammatory skin disease affecting approximately 3.3 million Americans. Hidradenitis Suppurativa, or HS, causes painful boil-like lesions, scarring, and significant physical and emotional suffering, and is associated with one of the highest suicide rates among skin diseases. The resolution highlights that about 75 percent of people with HS are misdiagnosed or diagnosed after age 25, delaying critical treatment and worsening disease progression, which increases healthcare costs and impacts patients' ability to work and maintain relationships. The resolution calls for increased awareness among the public and healthcare professionals, improved screening and diagnosis, expanded biomedical research, and better access to the three currently FDA-approved biologic therapies. This is a symbolic measure with no direct funding or mandates, designed to draw attention to the disease and encourage continued efforts to develop new treatments and improve care.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.